Dry powder inhalers show benefits for asthma control, environment
Feb 08, 2022
Switching to dry powder inhaler more than halves carbon footprint of asthma treatment without asthma worsening
Inhaler receives Arthritis Foundation ‘Ease of Use’ commendation
Jan 17, 2018
Boehringer Ingelheim’s Respimat Inhaler, designed for those with arthritis, has received the Arthritis Foundation Ease of Use Commendation.
FDA approves Anoro Ellipta
Dec 20, 2013
The U.S. Food and Drug Administration have approved GlaxoSmithKline’s Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive pulmonary disease.